News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncoscience | SLFN11’s Surveillance Role in Protein Homeostasis

Oncoscience

August 3, 2022
PRESS RELEASE: A new research perspective was published on July 25, 2022, in Volume 9 of Oncoscience, entitled, “SLFN11’s surveillance role in protein homeostasis.” continue reading »

Oncotarget | Chemoradiation Alters PD-L1, CD8+ TILs and Mucin in Rectal Cancer

News

August 2, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 28, 2022, entitled, “Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer.” continue reading »

Aging | Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease

Aging

August 1, 2022
PRESS RELEASE: A new research paper was published in Aging on the cover of Volume 14, Issue 14, entitled, “Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease.” continue reading »

Aging | Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice

Aging

July 28, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 13, entitled, “Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice.” continue reading »

Oncotarget | CUDC907 promotes apoptosis of NF2 Schwannoma cells

Oncotarget

July 26, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.” continue reading »